|
|
|||
|
||||
OverviewCRISPR Empire continues the BioLionaire Scientist series by examining how clustered regularly interspaced short palindromic repeats (CRISPR) evolved from a bacterial immune curiosity into one of the most disruptive platforms in biotechnology history. This volume connects molecular precision with venture-scale execution. It explores how CRISPR-Cas systems transitioned from genome-editing tools to therapeutic pipelines, agricultural innovations, synthetic biology engines, and multibillion-dollar biotech companies. Rather than presenting gene editing as a single breakthrough, the book analyzes the layered architecture behind platform dominance: mechanism discovery, programmable design, delivery challenges, regulatory risk, intellectual property battles, manufacturing realities, and translational funding strategy. Written for scientists, translational researchers, and biotech builders, this volume moves from core CRISPR biology to competitive landscapes and capital formation - demonstrating how gene editing becomes not only a technology, but an empire. Who This Book Is ForThis volume is written for graduate students, postdoctoral researchers, clinician-scientists, synthetic biology innovators, translational research teams, and biotechnology entrepreneurs seeking a serious understanding of genome-editing strategy. It is also appropriate for academic libraries, biotech incubators, and institutions training the next generation of platform builders. Table of ContentsPart I - The Science of Editing Life Chapter 1 - The CRISPR Code Chapter 2 - The Tools of Precision Chapter 3 - From Lab to Life Part II - CRISPR in Action Chapter 4 - CRISPR in Cancer Chapter 5 - Editing Beyond Cancer Chapter 6 - The Diagnostic Revolution Part III - The Business of Editing Chapter 7 - The CRISPR Companies Chapter 8 - Patent Wars - The CRISPR Empire Chapter 9 - Ethics, Equity, and the Human Future Part IV - The Next Frontier Chapter 10 - CRISPR 3.0: The Intelligent Genome Chapter 11 - CRISPR 3.0 Founder-Ready Playbook Appendices Appendix A - One Page Protocols Appendix B - Investor Lens Glossary Index Companies Discussed in this Volume Essential Reading Available Editions - Kindle eBook (Full-Color Edition) - Paperback - Black & White Reading Edition - Premium Hardcover - Full-Color Flagship & Collector's Edition Full Product DetailsAuthor: Anahita Moraveji , Mehrnoosh Alinouri , Saina BijanzadehPublisher: Independently Published Imprint: Independently Published Dimensions: Width: 17.80cm , Height: 1.80cm , Length: 25.40cm Weight: 0.585kg ISBN: 9798274461788Pages: 336 Publication Date: 02 March 2026 Audience: General/trade , General Format: Paperback Publisher's Status: Active Availability: Available To Order We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |
||||